• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Industry
    • Exhibits and Support & Visibility Opportunities
    • Industry Archives
  • Meetings
    • 2026 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2025 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2025 Proffered Presentations

2025 Proffered Presentations

 

← Back to Previous Page

 

S177: EVALUATION OF THE SAFETY OF TUMOR REMOVAL WITH CAPSULAR SPARING IN SCHWANNOMAS
Kentaro Watanabe, PhD; The Jikei UNiversity School of Medicine

Capsule-sparing surgery has emerged as a promising approach for preserving neural function in schwannoma surgery. This retrospective study evaluated the efficacy of this technique in 83 schwannoma cases (65 auditory neuromas, 10 jugular foramen tumors, 5 trigeminal schwannomas, and 3 facial nerve schwannomas) treated between 2019 and 2024.

Results demonstrated excellent outcomes, with 99% facial nerve preservation and 68% hearing preservation in auditory neuromas. Other schwannomas also exhibited favorable neural function preservation, although sensory deficits were observed in some trigeminal schwannoma cases. While capsule identification was challenging in certain tumors, such as hypervascularized or recurrent ones, it significantly reduced the incidence of immediate postoperative facial paralysis and improved overall neural function outcomes.

These findings support the integration of capsule-sparing surgery into the standard of care for schwannoma treatment, emphasizing its potential to enhance patient outcomes and minimize functional deficits.

 

← Back to Previous Page

Copyright © 2025 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved